Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Centessa Pharmaceuticals (CNTA) Revenue (2022 - 2025)

Historic Revenue for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q1 2025 value amounting to $15.0 million.

  • Centessa Pharmaceuticals' Revenue changed N/A to $15.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 68365.76%. This contributed to the annual value of $6.9 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Revenue of $15.0 million as of Q1 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Revenue registered a high of $15.0 million during Q1 2025, and its lowest value of -$2.6 million during Q4 2023.
  • Its 3-year average for Revenue is -$242666.7, with a median of -$2.2 million in 2022.
  • Within the past 5 years, the most significant YoY rise in Centessa Pharmaceuticals' Revenue was 1665.91% (2023), while the steepest drop was 5633.33% (2023).
  • Centessa Pharmaceuticals' Revenue (Quarter) stood at -$2.2 million in 2022, then decreased by 16.66% to -$2.6 million in 2023, then skyrocketed by 683.66% to $15.0 million in 2025.
  • Its Revenue stands at $15.0 million for Q1 2025, versus -$2.6 million for Q4 2023 and -$2.5 million for Q3 2023.